IRCare Sdn Bhd

IRCare Sdn Bhd was founded by Ms. Jayse Ong and Ms. Daena Chan, emerging from a rich history of research, development, and innovation established by its parent company, Hyirox Sdn Bhd. Since 2013, Hyirox has been at the forefront of developing hydrogen-based technologies, paving the way for new and advanced applications in healthcare. Building on this foundation, IRCare was created with a mission to redefine healthcare through technology, aiming to deliver innovative, non-invasive solutions that enhance patient care and improve quality of life. Our flagship product, Hi-Bliss Hydrogen Therapy, represents our first proprietary technology and is designed to address pain management and promote overall wellness through a unique application of molecular hydrogen. This pioneering therapy leverages the natural healing properties of hydrogen to provide effective relief and improve health outcomes without the need for invasive procedures or pharmaceuticals. In addition to Hi-Bliss Hydrogen Therapy, IRCare is deeply invested in the development and integration of advanced healthcare technologies. We are committed to exploring new frontiers in medical innovation, continually refining our offerings to meet the evolving needs of patients and healthcare providers alike. Our focus on rigorous R&D and strategic partnerships enables us to stay at the cutting edge of the healthcare sector, bringing forward the next generation of therapeutic solutions. At IRCare, our vision is clear: to lead the way in healthcare innovation by combining state-of-the-art technology with a patient-centered approach. We strive to create solutions that are not only effective and safe but also accessible and convenient, empowering individuals to take control of their health and wellness. As we continue to grow and expand our portfolio, we remain dedicated to making a meaningful impact in the lives of those we serve, both in Malaysia and beyond.